Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06273111Phase 1Not yet recruiting
Phase 1, open-label, single-arm trial of simvastatin gel (Ain Shams University) in infantile hemangioma (IH). Primary endpoint: Evaluation of the safety and tolerability of the 5% simvastatin ointment at 48 weeks. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06273111.